Benralizumab News
Benralizumab currently has 0 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Benralizumab with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: AsthmaFasenra is indicated as an add on maintenance treatment in adult patients with severe eosinophilic asthma inadequately controlled despite high-dose inhaled corticosteroids plus long acting β...
- Evidence level: L5
- Predicted indications (20):
- thrombocytopenia due to immune destruction (99.3%)
- dermatitis (99.2%)
- acne keloid (99.1%)
- neonatal dermatomyositis (99.0%)
- amyopathic dermatomyositis (99.0%)
- acrodermatitis chronica atrophicans (98.9%)
- secondary interstitial lung disease specific to childhood associated with a connective tissue disease (98.9%)
- hydroa vacciniforme, familial (98.9%)
- autoimmune thrombocytopenic (98.4%)
- Evans syndrome (98.2%)
- autosomal thrombocytopenia with normal platelets (97.8%)
- primary release disorder of platelets (97.8%)
- neonatal thrombocytopenia (97.3%)
- pseudo-von Willebrand disease (97.1%)
- mixed-type autoimmune hemolytic anemia (96.8%)
- drug-induced autoimmune hemolytic anemia (96.6%)
- Glanzmann thrombasthenia (96.2%)
- neonatal autoimmune hemolytic anemia (95.9%)
- proteinuria (95.8%)
- filariasis (95.6%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.